Short answer
Syphilis testing is a two-test system by necessity, not redundancy: treponemal tests answer “ever infected?” (staying positive for life), while non-treponemal RPR/VDRL titers answer “active now, and responding to treatment?” Together with exposure timing, the pair stages disease, guides therapy, and verifies cure across months of follow-up.
Understanding both halves prevents the two classic errors. Treating history as active disease, and dismissing active disease as history.
Advertisement
Need a test? STDTest.online is education-only and does not provide testing. The banner above is a paid advertisement for an independent testing service. We may earn a commission if you use it, at no extra cost to you. Always confirm current prices, accreditation, and privacy terms on their website before ordering.
See Tests & Prices →The two algorithms laboratories use
Traditional: non-treponemal screen (RPR/VDRL) first; reactive results confirm with treponemal testing.
Reverse: treponemal screen first (automation-friendly); positives get non-treponemal titers; discordance gets a second treponemal tiebreaker.
Labs choose by workflow; clinicians interpret both identically.
Patients see the algorithm as multi-line reports. Read every line, because screening and confirmatory lines mean different things.
See How to Read a Laboratory STI Report.
Windows and direct detection gaps
Seroconversion typically completes 3–6 weeks after exposure. Testing earlier misses developing infection, so exposure-dated retests matter.
Primary chancres may precede antibodies by days; darkfield microscopy or direct lesion tests cover the gap where available (rare in routine practice, more common in STI specialty clinics).
HIV coinfection can blunt, delay, or complicate serologic responses: HIV-positive patients get more intensive testing and follow-up by default.
Titer interpretation across months
- Higher titers (e.g., 1:64) suggest active disease
- fourfold declines (e.g., 1:64 → 1:16) confirm treatment response. The benchmark of cure
- fourfold rises flag reinfection demanding retreatment and partner re-evaluation
- persistently low “serofast” titers (e.g., stable 1:1–1:4) need clinical judgment distinguishing scar from smolder.
Consistent laboratory methods across follow-ups matter. Switching labs mid-series muddies trends, so keep titer series at one laboratory where possible.
Follow-up schedule by situation
Early syphilis: titer checks at defined months expecting fourfold declines.
Late latent: longer series.
HIV-coinfected: intensified schedules with lower thresholds for lumbar puncture. Neurosyphilis, ocular, or otic involvement: spinal-fluid examination plus specialist co-management.
Pregnancy: monthly titers with treatment timing verified 30+ days pre-delivery.
Every schedule serves the same purpose. Documented serologic cure, not assumed cure.
When to seek care
For sores or rashes (test even when textbook-classic. Mimics abound), after exposures past the window period, during pregnancy per screening schedules, on every titer follow-up date without exception, and urgently for vision, hearing, or neurologic changes with any syphilis history.